Dr. Gayathri Devi, Duke University
Toxicology Auditorium 2104One Network: Precision Health and Community Partnerships to Address Breast Cancer Health Disparity
One Network: Precision Health and Community Partnerships to Address Breast Cancer Health Disparity
No REST for the weak: Neuroimmune and epigenetic mechanisms underlying reversible suppression of cholinergic neuron phenotype
Human Exposure and Health Effects of Organo-Phosphate Based Flame Retardants
Strobilurins - Are they the next mitochondrial toxicant of concern for neurotoxicity? If so, how?
From science to policy: air pollution, reproduction, and development
Puff or Pass? Assessing the Health Risks of E-Cigarettes and Vaping Products in a Rapidly Evolving Industry
Connecting MASLD. Liver Cancer and our Environment. How did I (we) get here?
Emerging Carcinogens: Using Multiomics to Interrogate the Role of PFAS in Liver Cancer Development
Molecular Toxicology and its Multiple Faces at the ChEMTox Lab
Modeling the occult tumorigenic phase reveals ecological mechanisms of tumor initiation and metastasis
The IARC process of evaluating potential carcinogens: recent findings for PFOA and PFOS
DNA methylation of imprint control regions in brain and blood associated with Alzheimer's disease in non-Hispanic Blacks and non-Hispanic Whites